MyRisk Hereditary Cancer Test siderail

Take the next step with MyRiskTM

Interested in learning more about the MyRisk test and your ordering options? Fill out the form below to get started.

Request information

Order MyRisk

Resources

MyRiskTM Hereditary Cancer Test

The all-in-one hereditary cancer test, risk assessment, and care plan

MyRisk with RiskScore® is a powerful tool that evaluates 48 genes to help healthcare providers identify their patients’ risk of developing 11 different types of hereditary cancer.

More than a test, MyRisk’s clear, actionable results are the foundation for personalized care plans that can be used to help patients make confident, informed decisions about their medical management.

MyRiskTM Hereditary Cancer Test

The all-in-one hereditary cancer test, risk assessment, and care plan

MyRisk with RiskScore® is a powerful tool that evaluates 48 genes to help healthcare providers identify their patients’ risk of developing 11 different types of hereditary cancer. More than a test, MyRisk’s clear, actionable results are the foundation for personalized care plans that can be used to help patients make confident, informed decisions about their medical management.

Why MyRisk?

For patients with family history of certain cancers, hereditary cancer testing is the primary way to determine if they are at an increased risk of developing specific types of cancer.

MyRisk with RiskScore evaluates 48 genes associated with hereditary cancer risk to identify genetic changes associated with an increased cancer risk. When combined with family history and other clinical factors, MyRisk with RiskScore provides each patient with a cancer risk assessment individualized to them.

Nearly 1 in 4 patients1 meet criteria for hereditary cancer testing

MyRiskTM Hereditary Cancer Test

MyRisk is more than a test

Delivers personalized care plans

The MyRisk Management Tool offers personalized guidance for patients and providers to work together to reduce risk of developing cancer or detect it at an earlier, more treatable stage.

Guides medical management decisions

Because of the precision science behind MyRisk, 56% of patients2 qualify for a medical management change that may help lower cancer risk, as opposed to only 10% with other hereditary cancer tests.

Gives a precise answer about breast cancer risk

As the only hereditary cancer test designed for patients of all ancestries, the RiskScore component of MyRisk gives patients both a five-year and lifetime risk estimate of developing breast cancer. This is calculated using a combination of clinical risk factors, family history, and unique genetic, ancestry-informed breast cancer risk markers.

Complete results for personalized cancer risk management

Every MyRisk test report provides a personalized assessment of a patient’s hereditary cancer risk, providing healthcare providers and patients with clear information to make informed decisions about managing cancer risk.

  • Comprehensive risk assessment

    MyRisk assesses patient risk beyond just positive or negative, offering the following results:

    Positive
    Elevated
    Negative

  • MyRisk Management Tool

    The MyRisk Management Tool offers personalized guidance for patients with a higher risk of cancer. These plans may include guidelines for increased surveillance, risk- reducing medications, and/or risk-reducing surgery.

  • RiskScore for all ancestries

    Eligible patients will be provided with a RiskScore which gives a personalized estimate of their five-year and remaining lifetime risk for developing breast cancer, guiding more confident decisions in managing their breast cancer risk.

How to test with MyRisk

Myriad offers several MyRisk ordering options to better serve your patients and your practice, including portals for online ordering and options for sending MyRisk test kits directly to your patients’ homes.

Integrate MyRisk into your practice with Myriad Complete™

Myriad Complete supports patients and healthcare providers throughout the genetic testing experience through pre-test education, transparent pricing and financial support, clear results reporting, and post-test education.  

Real expert support

First-class support from our team of board-certified genetic counselors gives you on-demand access to the information you need for every patient, every test, every time.

Workflows

Workflow solutions allow for simple integration of Myriad’s tests into routine clinical care and help patients better understand and benefit from their results. 

Myriad Complete video playerPlay video icon overlay lightbox

What to expect with every MyRisk test

Actionable

MyRisk offers clinically actionable results and personalized medical management guidance to inform confident patient care.

Affordable

Myriad is committed to providing patients with access to accurate and affordable genetic results through extensive coverage with most insurance plans and financial assistance programs. 

Accurate

Myriad believes in providing the most accurate and highest quality tests for patients. From hereditary cancer to precision medicine, our tests are designed to give clinicians and patients the most accurate answer possible. 

MyRisk resources

References:

  1. DeFrancesco et al. Hereditary Cancer Risk Assessment and Genetic Testing in the Community-Practice Setting. Obstetrics & Gynecology 2018 – published online before print October 10, 2018.
  2. Myriad Internal Data based on OBGYN and Primary Care Settings, Sept 2019
MyRisk Hereditary Cancer Test siderail